bioAffinity Technologies (BIAF) Notes Payables (2021 - 2026)

bioAffinity Technologies has disclosed Notes Payables across 5 years of filings, most recently posting $61141.0 for Q1 2026.

• In Q1 2026, Notes Payables fell 41.64% year-over-year to $61141.0; the TTM figure through Mar 2026 stood at $61141.0 (down 41.64% YoY), while the FY2025 annual figure was $105161.0, down 38.74% from the prior year.
• Notes Payables slipped to $61141.0 in Q1 2026, from $105161.0 in the prior quarter.
• Over the last five years, Notes Payables for BIAF reached as high as $325000.0 in Q3 2022 and fell as low as $4106.0 in Q2 2024.
• The 4-year median for Notes Payables is $104963.5 (2025), against an average of $121295.2.
• Annual changes were most pronounced in 2022 — Notes Payables slumped 63.89% — and 2025, when it jumped 2135.72%.
• A 4-year view of Notes Payables shows it stood at $325000.0 in 2022, then slumped by 47.18% to $171669.0 in 2024, then sank by 38.74% to $105161.0 in 2025, then plunged by 41.86% to $61141.0 in 2026.
• According to Business Quant data, Notes Payables over the past three periods registered $61141.0, $105161.0, and $136396.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.